|
|
Volumn 4, Issue 4, 2004, Pages 224-225
|
|
The genetics of vitamin K antagonists
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVITAMIN K;
BLOOD CLOTTING FACTOR;
BLOOD CLOTTING FACTOR 10;
BLOOD CLOTTING FACTOR 7;
BLOOD CLOTTING FACTOR 9;
COUMARIN DERIVATIVE;
CYTOCHROME P450 2C9;
MENADIONE EPOXIDE;
NEW DRUG;
NUCLEOTIDE;
OXIDOREDUCTASE;
PHYTOMENADIONE;
PROTHROMBIN;
RNA;
VITAMIN K GROUP;
WARFARIN;
XIMELAGATRAN;
BLEEDING DISORDER;
BLOOD CLOTTING FACTOR DEFICIENCY;
CARBOXYLATION;
CHROMOSOME 16;
CLINICAL TRIAL;
COMPLEX FORMATION;
DRUG MECHANISM;
DRUG RESISTANCE;
ENDOPLASMIC RETICULUM;
ENZYME ACTIVITY;
ENZYME INHIBITION;
EXPERIMENTATION;
FAMILIAL DISEASE;
GENE EXPRESSION;
GENETIC VARIABILITY;
HUMAN;
IN VIVO STUDY;
MISSENSE MUTATION;
NONHUMAN;
NOTE;
NUCLEOTIDE SEQUENCE;
PHARMACOGENETICS;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
RNA INTERFERENCE;
SINGLE NUCLEOTIDE POLYMORPHISM;
ANIMALS;
ANTICOAGULANTS;
COUMARINS;
HUMANS;
MIXED FUNCTION OXYGENASES;
VITAMIN K;
|
|
EID: 4344645761
PISSN: 1470269X
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.tpj.6500258 Document Type: Note |
|
Times cited : (16)
|
|
References (11)
|
